Published in Expert Rev Dermatol on April 01, 2010
Staphylococcus aureus activation of caspase 1/calpain signaling mediates invasion through human keratinocytes. J Infect Dis (2012) 1.66
Neonatal sepsis due to coagulase-negative staphylococci. Clin Dev Immunol (2013) 1.16
Innate and adaptive immune responses against Staphylococcus aureus skin infections. Semin Immunopathol (2011) 1.12
Colonization and infection of the skin by S. aureus: immune system evasion and the response to cationic antimicrobial peptides. Int J Mol Sci (2014) 1.03
18β-Glycyrrhetinic acid inhibits methicillin-resistant Staphylococcus aureus survival and attenuates virulence gene expression. Antimicrob Agents Chemother (2012) 0.88
High throughput screening methods for assessing antibiofilm and immunomodulatory activities of synthetic peptides. Peptides (2015) 0.82
Bacterial strategies of resistance to antimicrobial peptides. Philos Trans R Soc Lond B Biol Sci (2016) 0.82
Transplantation of human skin microbiota in models of atopic dermatitis. JCI Insight (2016) 0.80
Molecular characterization of skin microbiota between cancer cachexia patients and healthy volunteers. Microb Ecol (2014) 0.80
Comparison of antibiotic resistance, biofilm formation and conjugative transfer of Staphylococcus and Enterococcus isolates from International Space Station and Antarctic Research Station Concordia. Microb Ecol (2013) 0.78
Is the Colonisation of Staphylococcus aureus in Pets Associated with Their Close Contact with Owners? PLoS One (2016) 0.78
Draft Genome Sequences of 11 Staphylococcus epidermidis Strains Isolated from Wild Mouse Species. Genome Announc (2014) 0.76
Global antibody response to Staphylococcus aureus live-cell vaccination. Sci Rep (2016) 0.76
Validation of picogram- and femtogram-input DNA libraries for microscale metagenomics. PeerJ (2016) 0.76
AraC-Type Regulator Rsp Adapts Staphylococcus aureus Gene Expression to Acute Infection. Infect Immun (2015) 0.76
Antibacterial fatty acids destabilize hydrophobic and multicellular aggregates of biofilm in S. aureus. J Antibiot (Tokyo) (2016) 0.75
Structural and functional analysis of betaine aldehyde dehydrogenase from Staphylococcus aureus. Acta Crystallogr D Biol Crystallogr (2015) 0.75
Pathogenic conversion of coagulase-negative staphylococci. Microbes Infect (2016) 0.75
Superantigen-Producing Staphylococcus aureus Elicits Systemic Immune Activation in a Murine Wound Colonization Model. Toxins (Basel) (2015) 0.75
Comparative Study on Antistaphylococcal Activity of Lipopeptides in Various Culture Media. Antibiotics (Basel) (2017) 0.75
Staphylococcus aureus infections. N Engl J Med (1998) 36.39
Invasive methicillin-resistant Staphylococcus aureus infections in the United States. JAMA (2007) 26.98
Antimicrobial peptides of multicellular organisms. Nature (2002) 23.50
Complete genome sequence of USA300, an epidemic clone of community-acquired meticillin-resistant Staphylococcus aureus. Lancet (2006) 15.99
National Nosocomial Infections Surveillance (NNIS) System Report, data summary from January 1992 through June 2004, issued October 2004. Am J Infect Control (2004) 14.85
Nasal carriage as a source of Staphylococcus aureus bacteremia. Study Group. N Engl J Med (2001) 14.84
Quorum sensing in bacteria. Annu Rev Microbiol (2001) 14.41
Defensins: antimicrobial peptides of innate immunity. Nat Rev Immunol (2003) 11.11
The changing epidemiology of Staphylococcus aureus? Emerg Infect Dis (2001) 10.43
The role of nasal carriage in Staphylococcus aureus infections. Lancet Infect Dis (2005) 9.80
Endogenous antimicrobial peptides and skin infections in atopic dermatitis. N Engl J Med (2002) 9.01
Bacterial interference caused by autoinducing peptide variants. Science (1997) 7.96
Beta-defensins: linking innate and adaptive immunity through dendritic and T cell CCR6. Science (1999) 7.86
Identification of novel cytolytic peptides as key virulence determinants for community-associated MRSA. Nat Med (2007) 7.75
Bacteriocins of gram-positive bacteria. Microbiol Rev (1995) 7.68
Exotoxins of Staphylococcus aureus. Clin Microbiol Rev (2000) 7.35
Immune evasion by staphylococci. Nat Rev Microbiol (2005) 7.22
MSCRAMM-mediated adherence of microorganisms to host tissues. Annu Rev Microbiol (1994) 7.14
Surface protein adhesins of Staphylococcus aureus. Trends Microbiol (1998) 6.86
Peptide antibiotics and their role in innate immunity. Annu Rev Immunol (1995) 6.81
Innate antimicrobial peptide protects the skin from invasive bacterial infection. Nature (2001) 6.71
Inactivation of the dlt operon in Staphylococcus aureus confers sensitivity to defensins, protegrins, and other antimicrobial peptides. J Biol Chem (1999) 6.44
Cutting edge: 1,25-dihydroxyvitamin D3 is a direct inducer of antimicrobial peptide gene expression. J Immunol (2004) 6.35
Isolation and characterization of human beta -defensin-3, a novel human inducible peptide antibiotic. J Biol Chem (2000) 6.19
Secrets of success of a human pathogen: molecular evolution of pandemic clones of meticillin-resistant Staphylococcus aureus. Lancet Infect Dis (2002) 6.18
Cell density control of staphylococcal virulence mediated by an octapeptide pheromone. Proc Natl Acad Sci U S A (1995) 6.13
Staphylococcus aureus sortase, an enzyme that anchors surface proteins to the cell wall. Science (1999) 5.98
The intercellular adhesin involved in biofilm accumulation of Staphylococcus epidermidis is a linear beta-1,6-linked glucosaminoglycan: purification and structural analysis. J Bacteriol (1996) 5.82
Staphylococcus epidermidis--the 'accidental' pathogen. Nat Rev Microbiol (2009) 5.34
Antimicrobial resistance: the example of Staphylococcus aureus. J Clin Invest (2003) 5.33
Risk and outcome of nosocomial Staphylococcus aureus bacteraemia in nasal carriers versus non-carriers. Lancet (2004) 5.27
Healthy carriage of Staphylococcus aureus: its prevalence and importance. Bacteriol Rev (1963) 5.19
Bacterial small-molecule signaling pathways. Science (2006) 5.14
Staphylococcus aureus resistance to human defensins and evasion of neutrophil killing via the novel virulence factor MprF is based on modification of membrane lipids with l-lysine. J Exp Med (2001) 5.06
Recognition of antimicrobial peptides by a bacterial sensor kinase. Cell (2005) 4.78
Metal chelation and inhibition of bacterial growth in tissue abscesses. Science (2008) 4.55
Prepeptide sequence of epidermin, a ribosomally synthesized antibiotic with four sulphide-rings. Nature (1988) 4.41
The co-evolution of host cationic antimicrobial peptides and microbial resistance. Nat Rev Microbiol (2006) 4.29
Staphylococcal biofilms. Curr Top Microbiol Immunol (2008) 4.26
The role of cationic antimicrobial peptides in innate host defences. Trends Microbiol (2000) 4.10
Distribution and persistence of Staphylococcus and Micrococcus species and other aerobic bacteria on human skin. Appl Microbiol (1975) 3.92
Structure-activity analysis of synthetic autoinducing thiolactone peptides from Staphylococcus aureus responsible for virulence. Proc Natl Acad Sci U S A (1999) 3.79
How do bacteria resist human antimicrobial peptides? Trends Microbiol (2002) 3.76
Urinary tract infection caused by Staphylococcus saprophyticus. J Infect Dis (1980) 3.67
Neutrophil granules and secretory vesicles in inflammation. Microbes Infect (2003) 3.56
Cathelicidins, multifunctional peptides of the innate immunity. J Leukoc Biol (2003) 3.56
Bacterial competition for human nasal cavity colonization: role of Staphylococcal agr alleles. Appl Environ Microbiol (2003) 3.51
Staphylococcus epidermidis infections. Microbes Infect (2002) 3.45
Cytokine milieu of atopic dermatitis, as compared to psoriasis, skin prevents induction of innate immune response genes. J Immunol (2003) 3.41
Mechanism of lysozyme action. Science (1969) 3.27
Polysaccharide intercellular adhesin (PIA) protects Staphylococcus epidermidis against major components of the human innate immune system. Cell Microbiol (2004) 3.26
Staphylococcus lugdunensis endocarditis. Lancet (1989) 3.21
Antimicrobial psoriasin (S100A7) protects human skin from Escherichia coli infection. Nat Immunol (2004) 3.19
The human antimicrobial and chemotactic peptides LL-37 and alpha-defensins are expressed by specific lymphocyte and monocyte populations. Blood (2000) 3.09
LL-37, the only human member of the cathelicidin family of antimicrobial peptides. Biochim Biophys Acta (2006) 3.05
A crucial role for exopolysaccharide modification in bacterial biofilm formation, immune evasion, and virulence. J Biol Chem (2004) 3.05
FALL-39, a putative human peptide antibiotic, is cysteine-free and expressed in bone marrow and testis. Proc Natl Acad Sci U S A (1995) 2.89
Why are pathogenic staphylococci so lysozyme resistant? The peptidoglycan O-acetyltransferase OatA is the major determinant for lysozyme resistance of Staphylococcus aureus. Mol Microbiol (2005) 2.76
A 140-kilodalton extracellular protein is essential for the accumulation of Staphylococcus epidermidis strains on surfaces. Infect Immun (1997) 2.65
Lantibiotics: mode of action, biosynthesis and bioengineering. Curr Pharm Biotechnol (2009) 2.56
Anchoring of surface proteins to the cell wall of Staphylococcus aureus. Sortase catalyzed in vitro transpeptidation reaction using LPXTG peptide and NH(2)-Gly(3) substrates. J Biol Chem (2000) 2.52
A novel Staphylococcus aureus biofilm phenotype mediated by the fibronectin-binding proteins, FnBPA and FnBPB. J Bacteriol (2008) 2.51
The antimicrobial peptide-sensing system aps of Staphylococcus aureus. Mol Microbiol (2007) 2.45
Staphylococcus aureus in the lesions of atopic dermatitis. Br J Dermatol (1974) 2.43
Identification of CRAMP, a cathelin-related antimicrobial peptide expressed in the embryonic and adult mouse. J Biol Chem (1997) 2.38
Degradation of human antimicrobial peptide LL-37 by Staphylococcus aureus-derived proteinases. Antimicrob Agents Chemother (2004) 2.34
Gram-positive three-component antimicrobial peptide-sensing system. Proc Natl Acad Sci U S A (2007) 2.34
Dermcidin: a novel human antibiotic peptide secreted by sweat glands. Nat Immunol (2001) 2.29
Induction of Staphylococcus epidermidis biofilm formation via proteolytic processing of the accumulation-associated protein by staphylococcal and host proteases. Mol Microbiol (2005) 2.29
Staphylococcus intermedius in canine gingiva and canine-inflicted human wound infections: laboratory characterization of a newly recognized zoonotic pathogen. J Clin Microbiol (1989) 2.24
Incorporation of D-alanine into lipoteichoic acid and wall teichoic acid in Bacillus subtilis. Identification of genes and regulation. J Biol Chem (1995) 2.23
Staphylococcus aureus osmoregulation: roles for choline, glycine betaine, proline, and taurine. J Bacteriol (1992) 2.20
hCAP-18, a cathelin/pro-bactenecin-like protein of human neutrophil specific granules. FEBS Lett (1995) 2.18
Staphylococcal innate immune evasion. Trends Microbiol (2005) 2.18
Inhibition of virulence factor expression in Staphylococcus aureus by the Staphylococcus epidermidis agr pheromone and derivatives. FEBS Lett (1999) 2.16
Local variants of Staphylococcal cassette chromosome mec in sporadic methicillin-resistant Staphylococcus aureus and methicillin-resistant coagulase-negative Staphylococci: evidence of horizontal gene transfer? Antimicrob Agents Chemother (2004) 2.12
Perineal carriage of Staph. aureus. Br Med J (1959) 2.11
Nasal carriage of Staphylococcus aureus and prevention of nosocomial infections. Infection (2005) 2.05
Host defense and pathogenesis in Staphylococcus aureus infections. Infect Dis Clin North Am (2009) 2.01
Structure of the pheromone peptide of the Staphylococcus epidermidis agr system. FEBS Lett (1998) 1.96
Propionibacterium acnes and lipopolysaccharide induce the expression of antimicrobial peptides and proinflammatory cytokines/chemokines in human sebocytes. Microbes Infect (2006) 1.91
Pep5, a new lantibiotic: structural gene isolation and prepeptide sequence. Arch Microbiol (1989) 1.85
SLPI and elafin: one glove, many fingers. Clin Sci (Lond) (2006) 1.84
Staphylococcus epidermidis: emerging resistance and need for alternative agents. Clin Infect Dis (1998) 1.83
An inflammatory polypeptide complex from Staphylococcus epidermidis: isolation and characterization. J Exp Med (1999) 1.82
Protein A-mediated multicellular behavior in Staphylococcus aureus. J Bacteriol (2008) 1.81
Staphylococcus aureus resists human defensins by production of staphylokinase, a novel bacterial evasion mechanism. J Immunol (2004) 1.80
Cutting edge: mast cell antimicrobial activity is mediated by expression of cathelicidin antimicrobial peptide. J Immunol (2003) 1.79
Cationic host defence peptides: innate immune regulatory peptides as a novel approach for treating infections. Cell Mol Life Sci (2007) 1.79
The cationic antimicrobial peptide LL-37 modulates dendritic cell differentiation and dendritic cell-induced T cell polarization. J Immunol (2004) 1.78
Identification of in vivo expressed vaccine candidate antigens from Staphylococcus aureus. Proc Natl Acad Sci U S A (2002) 1.75
Participation of mammalian defensins and cathelicidins in anti-microbial immunity: receptors and activities of human defensins and cathelicidin (LL-37). J Leukoc Biol (2001) 1.73
A zinc-dependent adhesion module is responsible for intercellular adhesion in staphylococcal biofilms. Proc Natl Acad Sci U S A (2008) 1.70
Development and characterization of a Staphylococcus aureus nasal colonization model in mice. Infect Immun (1999) 1.69
Genetic analysis of factors affecting susceptibility of Bacillus subtilis to daptomycin. Antimicrob Agents Chemother (2009) 1.67
The staphylococcal superantigen-like protein 7 binds IgA and complement C5 and inhibits IgA-Fc alpha RI binding and serum killing of bacteria. J Immunol (2005) 1.67
The mammalian ionic environment dictates microbial susceptibility to antimicrobial defense peptides. FASEB J (2006) 1.66